482 related articles for article (PubMed ID: 19666904)
1. Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer.
Namiki S; Ishidoya S; Ito A; Tochigi T; Numata I; Narazaki K; Yamada S; Takai Y; Arai Y
Jpn J Clin Oncol; 2009 Nov; 39(11):732-8. PubMed ID: 19666904
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: comparison with conventional and conformal radiotherapy.
Namiki S; Ishidoya S; Tochigi T; Kawamura S; Kuwahara M; Terai A; Yoshimura K; Numata I; Satoh M; Saito S; Takai Y; Yamada S; Arai Y
Jpn J Clin Oncol; 2006 Apr; 36(4):224-30. PubMed ID: 16537689
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
Lips I; Dehnad H; Kruger AB; van Moorselaar J; van der Heide U; Battermann J; van Vulpen M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):656-61. PubMed ID: 17512127
[TBL] [Abstract][Full Text] [Related]
4. Health related quality of life in Japanese men after radical prostatectomy or radiation therapy for localized prostate cancer.
Namiki S; Tochigi T; Kuwahara M; Ioritani N; Terai A; Numata I; Satoh M; Saito S; Koinuma N; Arai Y
Int J Urol; 2004 Aug; 11(8):619-27. PubMed ID: 15285752
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: intensity-modulated radiation therapy versus conformal radiation therapy.
Yoshimura K; Kamoto T; Nakamura E; Segawa T; Kamba T; Takahashi T; Nishiyama H; Ito N; Takayama K; Mizowaki T; Mitsumori M; Hiraoka M; Ogawa O
Prostate Cancer Prostatic Dis; 2007; 10(3):288-92. PubMed ID: 17160068
[TBL] [Abstract][Full Text] [Related]
7. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study.
Zapatero A; Valcárcel F; Calvo FA; Algás R; Béjar A; Maldonado J; Villá S
J Clin Oncol; 2005 Sep; 23(27):6561-8. PubMed ID: 16170164
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
[TBL] [Abstract][Full Text] [Related]
9. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
[TBL] [Abstract][Full Text] [Related]
10. Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapy.
Staff I; Salner A; Bohannon R; Panatieri P; Maljanian R
Cancer; 2003 Dec; 98(11):2335-43. PubMed ID: 14635067
[TBL] [Abstract][Full Text] [Related]
11. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
13. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study.
Namiki S; Satoh T; Baba S; Ishiyama H; Hayakawa K; Saito S; Arai Y
Urology; 2006 Dec; 68(6):1230-6. PubMed ID: 17141839
[TBL] [Abstract][Full Text] [Related]
14. No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study.
Marchand V; Bourdin S; Charbonnel C; Rio E; Munos C; Campion L; Bonnaud-Antignac A; Lisbona A; Mahé MA; Supiot S
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1053-9. PubMed ID: 19880259
[TBL] [Abstract][Full Text] [Related]
15. Quality of life outcomes after brachytherapy for early stage prostate cancer.
Brandeis JM; Litwin MS; Burnison CM; Reiter RE
J Urol; 2000 Mar; 163(3):851-7. PubMed ID: 10687991
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
Jayadevappa R; Chhatre S; Whittington R; Bloom BS; Wein AJ; Malkowicz SB
BJU Int; 2006 May; 97(5):955-62. PubMed ID: 16643477
[TBL] [Abstract][Full Text] [Related]
17. Impact of salvage therapy for biochemical recurrence on health-related quality of life following radical prostatectomy.
Namiki S; Saito S; Tochigi T; Ioritani N; Terai A; Arai Y
Int J Urol; 2007 Mar; 14(3):186-91. PubMed ID: 17430252
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer - a prospective analysis.
Pinkawa M; Fischedick K; Asadpour B; Gagel B; Piroth MD; Holy R; Krenkel B; Eble MJ
Radiother Oncol; 2008 Jul; 88(1):135-9. PubMed ID: 18022263
[TBL] [Abstract][Full Text] [Related]
19. IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy.
Alongi F; Fiorino C; Cozzarini C; Broggi S; Perna L; Cattaneo GM; Calandrino R; Di Muzio N
Radiother Oncol; 2009 Nov; 93(2):207-12. PubMed ID: 19766338
[TBL] [Abstract][Full Text] [Related]
20. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE.
Downs TM; Sadetsky N; Pasta DJ; Grossfeld GD; Kane CJ; Mehta SS; Carroll PR; Lubeck DP
J Urol; 2003 Nov; 170(5):1822-7. PubMed ID: 14532784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]